Medical Innovation Acceleration Act of 2025

Bill: 119-hr-88
Sponsor: full_name: Rep. Biggs, Andy [R-AZ-5]
Introduced: 2025-01-03
Latest action: action_date: 2025-01-03
text: Referred to the House Committee on Energy and Commerce.

Summaries:
action_date: 2025-01-03
action_desc: Introduced in House
text: <p><strong>Medical Innovation Acceleration Act of 2025</strong></p><p>This bill exempts noninvasive diagnostic devices from the regulatory authority of the Food and Drug Administration.</p><p>The bill defines <em>noninvasive diagnostic device</em> as one that does not penetrate the skin or any other membrane of the body, is not inserted or implanted into the body, causes no more than ephemeral compression or temperature changes to in situ bodily tissues, and does not subject bodily tissues to ionizing radiation.</p>

tv_txt: I 119th CONGRESS 1st Session H. R. 88 IN THE HOUSE OF REPRESENTATIVES January 3, 2025 Mr. Biggs of Arizona introduced the following bill; which was referred to the Committee on Energy and Commerce A BILL To amend the Federal Food, Drug, and Cosmetic Act to exempt from regulation as devices non-invasive diagnostic devices, and for other purposes.

1. Short title This Act may be cited as the Medical Innovation Acceleration Act of 2025 . 2. Exempting non-invasive diagnostic devices from regulation as devices Section 201(h) of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 321(h) ) is amended— (1) by striking section 520(o) and inserting the following: section 520(o) or any non-invasive diagnostic device ; and (2) by adding at the end the following: For purposes of the preceding sentence, the term non-invasive means, with respect to a diagnostic device, that the device does not penetrate the skin or any other membrane of the body, is not inserted or implanted into the body, causes no more than ephemeral compression or temperature changes to in situ bodily tissues, and does not subject bodily tissues to ionizing radiation. .